Management of canine diabetes

Veterinary Clinics of North America - Small Animal Practice

Volumn 31, Issue 5, 2001, Pages 855-880

  Fleeman, L M ^a   Rand, J S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIGUANIDE DERIVATIVE; ISOPHANE INSULIN; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE;

ACUTE PANCREATITIS; AUTOIMMUNE DISEASE; CATARACTOGENESIS; CHRONIC PANCREATITIS; DIABETES MELLITUS; DISEASE CLASSIFICATION; DOG; GLUCOSE BLOOD LEVEL; IMPAIRED GLUCOSE TOLERANCE; NONHUMAN; NUTRITION; PATHOGENESIS; REVIEW;

EID: 0034843390     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-5616(01)50003-0     Document Type: Review

References (98)

1. Advances in canine diabetes mellitus research: Etiopathology and results of islet transplantation
2. Dietary fiber - An overview
3. Pancreatic disease in dogs and cats
4. Comparison of postoperative phacoemulsification results in dogs with and without diabetes mellitus: 153 Cases (1991-1992)
5. A retrospective-cohort study on the development of cataracts in dogs with diabetes mellitus: 200 Cases
6. Measurement of plasma canine C-peptide by radioimmunoassay
7. Dietary fibre and post prandial hyperglycaemia in normal and diabetic dogs
8. Counterregulatory mechanisms to insulin-induced hypoglycemia in humans: Relevance to the problem of intensive treatment of IDDM
9. Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: Evidence for a nonselective defect
10. Serum fructosamine for monitoring glycemic control of diabetic dogs
11. Reliability of history and physical examination findings for assessing control of glycemia in dogs with diabetes mellitus: 53 Cases (1995-1998)
12. Home monitoring of capillary blood glucose in dogs and cats: Technical aspects
13. The blood glucose response to three prolonged duration insulins in canine diabetes mellitus
14. Canine diabetes mellitus: Some therapeutic considerations
15. Treating the complicated diabetic patient
16. Assessment of five portable blood glucose meters, a point-of-care analyzer, and color test strips for measuring blood glucose concentration in dogs
17. Canine pregnancy and parturition
18. Biology and endocrinology of ovulation, pregnancy and parturition in the dog
19. Diabetes mellltus in the dog: A clinicopathologic study
20. Pathological features of spontaneous canine diabetes mellitus
21. Impaired counterregulatory response to insulin-induced hypoglycemia in diabetic dogs
22. Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly
23. Canine immune mediated diabetes mellitus: A case report
24. Glycosylated hemoglobin concentrations in the blood of healthy dogs and dogs with naturally developing diabetes mellitus, pancreatic β-cell neoplasia, hyperadrenocorticism, and anemia
25. Diabetes mellitus
26. Diabetic ketoacidosis
27. Ovarian cycle and vaginal cytology
28. Reduced immunogenicity of pork insulin in dogs with spontaneous insulin-dependent diabetes mellitus (IDDM)
29. Canine C-peptide for characterisation of experimental diabetes in dogs
30. Comparison of serial blood glucose curves performed on consecutive days in diabetic dogs
31. The behavioral responses of pet dogs to capillary blood glucose testing
32. Efficacy of intermittent low-dose heparinised saline flushes for maintaining indwelling peripheral and central catheters in diabetic dogs
33. Efficacy of intermittent low-dose heparinised saline flushes for maintaining indwelling peripheral and central intravenous catheters in diabetic dogs
34. Long-term management of the diabetic dog
35. Insulin resistance in three dogs with hypothyroidism and diabetes mellitus
36. Retrospective evaluation of urinary tract infection in 42 dogs with hyperadrenocorticism or diabetes mellitus or both
37. Examination of immune reaction due to use of swine insulin in diabetic dogs
38. Effect of hypoglycemia on β-adrenergic sensitivity in normal and type 1 diabetic subjects
39. Familial canine diabetes mellitus
40. The critical evaluation of tests for monitoring glycemic control in canine diabetes mellitus
41. Rates of blindness and other complications in diabetic dogs
42. Survival data analysis applied to canine diabetes mellitus
43. Canned high fiber diet and postprandial glycemia in dogs with naturally occurring diabetes mellitus
44. A re-examination of islet cell cytoplasmic antibodies in diabetic dogs
45. Prevalence of insulin antibodies in diabetic dogs
46. Effect of insulin dosage on glycemic response in dogs with diabetes mellitus: 221 Cases (1993-1998)
47. Breed distribution of dogs with diabetes mellitus admitted to a tertiary care facility
48. A qualitative assay for beta cell antibodies. Preliminary results in dogs with diabetes mellitus
49. Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia
50. Glycated blood proteins in canine diabetes mellitus
51. Various protein and albumin corrections of the serum fructosamine concentration in the diagnosis of canine diabetes mellitus
52. Diagnostic and therapeutic approach to infertility in the bitch
53. The dietary management of diabetes
54. Immunoreactive dog C-peptide level in the pancreatic vein
55. Familial insulin-dependent diabetes mellitus in Samoyed dogs
56. Effects of insoluble and soluble dietary fiber on glycemic control in dogs with naturally occurring insulin-dependent diabetes mellitus
57. Reduced β-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness
58. Inherited, early-onset, insulin-requiring diabetes mellitus in Keeshond dogs
59. Effects of different glycaemic index foods and dietary fibre intake on glycaemic control in type 1 diabetic patients on intensive insulin therapy
60. Diabetes mellitus in dogs: A review of initial evaluation, immediate and long-term management, and outcome
61. Blood glycated hemoglobin evaluation in sick dogs
62. Epizootiologic patterns of diabetes mellitus in dogs
63. The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dogs
64. Diabetes mellitus in dogs: Relationship of obesity to glucose tolerance and insulin response
65. Effects of sex, ovarian cycles, pregnancy and lactation on insulin and glucose response to exogenous glucose and glucagon in dogs
66. Hypoglycemia unawareness in IDDM
67. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism
68. Effect of dietary fiber type and quantity on control of glycemia in diabetic dogs
69. Effect of dietary insoluble fiber on control of glycaemia in dogs with naturally acquired diabetes mellitus
70. Effect of the α-glucosidase inhibitor acarbose on control of glycemia in dogs with naturally acquired diabetes mellitus
71. Effects of dietary fiber supplementation on glycemic control in dogs with alloxan-induced diabetes mellitus
72. The immunogenicity of different insulins in several animal species
73. Decreased insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism
74. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction
75. Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: Selective amplification of insulin secretory burst mass
76. Glucose toxicity: Its pathogenesis and clinical significance
77. Effects of the α-glucosidase inhibitor acarbose on postprandial serum glucose and insulin concentrations in healthy dogs
78. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycaemic disorders
79. Anti-beta-cell immunity in insulinopenic diabetic dogs
80. Diabetic cataracts: Different incidence between dogs and cats
81. Natural estrous cycle in normal and diabetic bitches in relation to glucose and insulin tests
82. Effect of oral chromium picolinate on glycemic control in insulin-treated diabetic dogs
83. Progestin treatment in the dog I. Effects on growth hormone, insulin-like growth factor I and glucose homeostasis
84. Current concepts of the pathogenesis and pathophysiology of acute pancreatitis in the dog and cat
85. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets
86. Influence of chromium on glucose metabolism and insulin sensitivity
87. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
88. Treatment of diabetes mellitus in dogs using isophane insulin penfills and the use of serum fructosamine assays to diagnose and monitor the disease
89. Composition of dietary fat affects blood pressure and insulin responses to dietary obesity in the dog
90. Diabetes mellitus in a dog with a growth hormone-producing acidophilic adenoma of the adenohypophysis
91. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia
92. Capillary blood sampling from the ear of dogs and cats and use of portable meters to measure glucose concentration
93. Evaluation of five portable blood glucose meters for use in dogs
94. Insulin overdose in dogs and cats: 28 Cases (1986-1993)
95. Diagnosis and management of pancreatitis
96. Exocrine pancreatic disease
97. Erythrocyte insulin receptors in dogs with spontaneous hyperadrenocorticism
98. Latent autoimmune diabetes mellitus in adults (LADA): The role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency